ADAURA and the Evolving Role of Targeted Therapy
Podcast | English | 40 Min
Image For Activity Cover
No Credit Offered
Lung Cancer Considered hosts Dr. Narjust Florez and Dr. Stephen Liu talk with Dr. Roy Herbst about the ADAURA Trial. ADAURA introduced targeted therapy in the adjuvant setting for early-stage EGFR-positive NSCLC. While we have seen targeted therapy in this space, ADAURA showed DFS rates never seen before and changed the treatment of early-stage lung cancer.
Dr. Narjust Florez
Dr. Stephen Liu talk
Dr. Roy Herbst
Powered By